e184
Grand Cayman, Midland, Cayman Islands
Overview
e184 is an Advanced Research Funding Organization (ARFO) that supports frontier science and technology. We are living in an exponential age. The challenge is that humans are not used to it. Our skills and capabilities are not growing at an ever-increasing rate, and even the population growth rate has slowed down, failing to align with an exponent. At e184, our mission is to invest in science and technology that transforms humans into exponential species. Learn more at https://e184.com
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 1
Investment portfolio
- Paterna Biosciences
Participated · Seed · Oct 2024
Paterna BioSciences is a Salt Lake City biotechnology company focused on solving male infertility through in vitro spermatogenesis (IVS). Its core technology aims to grow healthy sperm in the laboratory from a male’s own cells as a novel treatment option. The company plans to partner with IVF clinics to enhance success rates, engage men in optimizing reproductive health, and expand treatment options for IVF. Paterna intends to use recently raised capital to accelerate IVS through preclinical development, build infrastructure, and grow its team. The company raised $6M in a Seed round. Paterna expects to enter early-phase studies in 2025 and ultimately bring its solution to market following FDA approval.
Team
Kirill Eves
Founder & GP
LinkedIn